Elekta AB (OTCMKTS:EKTAY) Short Interest Update

Elekta AB (OTCMKTS:EKTAY) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totaling 3,337 shares, a decline of 45.6% from the August 15th total of 6,134 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 6,268 shares, the short-interest ratio is presently 0.5 days.

Analysts Set New Price Targets

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Elekta has an average rating of “Hold”.

Elekta Trading Down 1.2%

Shares of OTCMKTS EKTAY opened at $5.22 on Thursday. The company has a quick ratio of 0.68, a current ratio of 0.87 and a debt-to-equity ratio of 0.47. The stock’s 50 day moving average price is $5.26 and its two-hundred day moving average price is $5.62. Elekta has a 52-week low of $4.35 and a 52-week high of $6.93. The stock has a market capitalization of $1.92 billion, a P/E ratio of -43.50 and a beta of 1.05.

Elekta (OTCMKTS:EKTAY) last issued its earnings results on Thursday, August 27th. The company reported $0.07 EPS for the quarter. The company had revenue of $372.30 million during the quarter. Elekta had a positive return on equity of 13.31% and a negative net margin of 2.38%. On average, analysts anticipate that Elekta will post 0.43 earnings per share for the current fiscal year.

Elekta Company Profile

Elekta AB is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software.